» Articles » PMID: 22377016

Escherichia Coli O104:H4 Infections and International Travel

Abstract

We analyzed travel-associated clinical isolates of Escherichia coli O104:H4, including 1 from the 2011 German outbreak and 1 from a patient who returned from the Philippines in 2010, by genome sequencing and optical mapping. Despite extensive genomic similarity between these strains, key differences included the distribution of toxin and antimicrobial drug-resistance determinants.

Citing Articles

Diversity of Potentially Pathogenic O104 and O9 Serogroups Isolated before 2011 from Fecal Samples from Children from Different Geographic Regions.

Navarro A, van der Ploeg C, Roge A, Licona-Moreno D, Delgado G, Morales-Espinosa R Microorganisms. 2021; 9(11).

PMID: 34835353 PMC: 8619403. DOI: 10.3390/microorganisms9112227.


Travel-Related Antimicrobial Resistance: A Systematic Review.

Bokhary H, Pangesti K, Rashid H, Abd El Ghany M, Hill-Cawthorne G Trop Med Infect Dis. 2021; 6(1).

PMID: 33467065 PMC: 7838817. DOI: 10.3390/tropicalmed6010011.


BacWGSTdb 2.0: a one-stop repository for bacterial whole-genome sequence typing and source tracking.

Feng Y, Zou S, Chen H, Yu Y, Ruan Z Nucleic Acids Res. 2020; 49(D1):D644-D650.

PMID: 33010178 PMC: 7778894. DOI: 10.1093/nar/gkaa821.


Enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4 in Belgium and Luxembourg.

De Rauw K, Vincken S, Garabedian L, Levtchenko E, Hubloue I, Verhaegen J New Microbes New Infect. 2014; 2(5):138-43.

PMID: 25356363 PMC: 4184478. DOI: 10.1002/nmi2.58.


Whole-genome mapping: a new paradigm in strain-typing technology.

Miller J J Clin Microbiol. 2013; 51(4):1066-70.

PMID: 23363821 PMC: 3666824. DOI: 10.1128/JCM.00093-13.


References
1.
Hadler J, Clogher P, Hurd S, Phan Q, Mandour M, Bemis K . Ten-year trends and risk factors for non-O157 Shiga toxin-producing Escherichia coli found through Shiga toxin testing, Connecticut, 2000-2009. Clin Infect Dis. 2011; 53(3):269-76. DOI: 10.1093/cid/cir377. View

2.
Gould L, Bopp C, Strockbine N, Atkinson R, Baselski V, Body B . Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep. 2009; 58(RR-12):1-14. View

3.
Chui L, Couturier M, Chiu T, Wang G, Olson A, McDonald R . Comparison of Shiga toxin-producing Escherichia coli detection methods using clinical stool samples. J Mol Diagn. 2010; 12(4):469-75. PMC: 2893631. DOI: 10.2353/jmoldx.2010.090221. View

4.
Brooks J, Sowers E, Wells J, Greene K, Griffin P, Hoekstra R . Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis. 2005; 192(8):1422-9. DOI: 10.1086/466536. View

5.
Pitout J, Hamilton N, Church D, Nordmann P, Poirel L . Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae. Clin Microbiol Infect. 2007; 13(3):291-7. DOI: 10.1111/j.1469-0691.2006.01645.x. View